BioXcel Therapeutics Inc (BTAI) — Financial Flexibility Index
BioXcel Therapeutics Inc (BTAI) has a Financial Flexibility Index of -0.08x as of March 2026. Free cash flow of $-11.81 Million (operating CF $-11.81 Million minus capex $0.00) represents 0% of total liabilities ($139.57 Million). Check BTAI strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
BioXcel Therapeutics Inc Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for BioXcel Therapeutics Inc across 11 annual periods. See BTAI working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for BioXcel Therapeutics Inc (2015–2025)
Year-by-year free cash flow to debt coverage for BioXcel Therapeutics Inc. For the full company profile including market capitalisation, see how much is BioXcel Therapeutics Inc worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.41x | $-57.62 Million | $-57.62 Million | $140.38 Million | ▲ +25.1% |
| 2024 | -0.55x | $-72.03 Million | $-72.03 Million | $131.44 Million | ▲ +54.0% |
| 2023 | -1.19x | $-154.99 Million | $-155.01 Million | $130.21 Million | ▼ -13.6% |
| 2022 | -1.05x | $-135.20 Million | $-135.34 Million | $129.08 Million | ▲ +77.2% |
| 2021 | -4.60x | $-81.71 Million | $-82.15 Million | $17.77 Million | ▲ +7.8% |
| 2020 | -4.99x | $-66.03 Million | $-66.35 Million | $13.24 Million | ▼ -79.3% |
| 2019 | -2.78x | $-26.41 Million | $-27.28 Million | $9.50 Million | ▲ +1.6% |
| 2018 | -2.83x | $-13.17 Million | $-13.51 Million | $4.66 Million | ▼ -255.8% |
| 2017 | -0.79x | $-1.86 Million | $-2.20 Million | $2.34 Million | ▲ +79.6% |
| 2016 | -3.90x | $-1.29 Million | $-1.29 Million | $331.00K | ▼ -144.5% |
| 2015 | -1.59x | $-279.00K | $-280.00K | $175.00K | — |